Trial
NCT05142228
Erenumab-aooe for the Management of Trigeminal Neuropathic Pain.
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Maryland, Baltimore
Collaborators
Amgen
Condition
Trigeminal Neuropathy
Intervention
Erenumab-Aooe
Why stopped
Low enrollment rate
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-03-22